Internal Medicine, Cardiovascular Disease · San Juan, PR
NPI
1134235187
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Street 21 Num. 1781, Hosp. Metropolitano 1-Floor Suite 103
San Juan, PR, 00921
Phone (787) 783-6620
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
468 services
Medicare patients, 2024
96
Average age 78
Drug cost, 2024
$3.9M
36,080 prescriptions
Company payments, 2025
$186
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Padilla was code 99213 (office e&m - established), 207 times for 85 patients. In total Jose A Padilla billed 468 services in 11 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 207 | 85 | $51.13 | $11K |
| 93000 Electrocardiogram | Office | 165 | 82 | $8.24 | $1,359 |
| 93306 Echocardiography (TTE/TEE) | Office | 32 | 32 | $94.73 | $3,031 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 27 | 27 | $132.67 | $3,582 |
By year: 2022 $33K for 684 services; 2023 $27K for 556 services; 2024 $20K for 468 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Padilla prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,547 prescriptions and refills. In total Jose A Padilla wrote 36,080 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,547 | 4,487 | 537 | $24K |
| Rosuvastatin Calcium Generic | 1,504 | 4,288 | 498 | $26K |
| Losartan Potassium Generic | 1,439 | 4,103 | 472 | $21K |
| Simvastatin Generic | 1,216 | 3,442 | 392 | $14K |
| Metoprolol Succinate Generic | 1,189 | 3,395 | 384 | $33K |
| Synthroid Levothyroxine Sodium | 1,182 | 3,185 | 371 | $149K |
| Gabapentin Generic | 989 | 2,709 | 336 | $15K |
| Metformin Hcl Generic | 941 | 2,667 | 323 | $8,934 |
| Ezetimibe Generic | 810 | 2,333 | 288 | $21K |
| Famotidine Generic | 807 | 1,681 | 244 | $9,421 |
| Levothyroxine Sodium Generic | 797 | 2,217 | 260 | $15K |
| Amlodipine Besylate Generic | 787 | 2,242 | 269 | $5,297 |
| Clopidogrel Clopidogrel Bisulfate | 745 | 2,175 | 258 | $13K |
| Enalapril Maleate Generic | 675 | 1,928 | 215 | $31K |
| Pantoprazole Sodium Generic | 661 | 1,421 | 192 | $8,685 |
Brand drugs: 4,831 claims; generic drugs: 31,222 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Padilla $186 ($186 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $75.98.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.